Results 181 to 190 of about 73,252 (267)

Clinical reality for adjunctive rifampin usage in infective endocarditis treatment

Elif Mukime Sarıcaoğlu, Nuran Sarı, Merve Aslan, Yasemin Tezer Tekçe, Yeşim Uygun Kızmaz, Serap Şimşek Yavuz, Özlem Kurt Azap   +6 more
openalex   +1 more source

Bactericidal Action of Gatifloxacin, Rifampin, and Isoniazid on Logarithmic- and Stationary-Phase Cultures of Mycobacterium tuberculosis

, 2005
C N Paramasivan, S. Sulochana, G Kubendiran, Prem Venkatesan, D.A. Mitchison   +4 more
openalex   +2 more sources

Rifampin Use in Staphylococcal Prosthetic Joint Infections. [PDF]

Cureus
Shah K, Baladad CB, Ritter AS, DeSear K.
europepmc   +1 more source

Antagonism Between Nafcillin or Oxacillin and Rifampin Against Staphylococcus aureus

, 1982
Chatrchai Watanakunakorn, Joann C. Tisone   +1 more
openalex   +2 more sources

Antibiotic Antagonism in <i>Orientia tsutsugamushi</i> Infection: A Narrative Review. [PDF]

Infect Chemother
Chung MH, Kang JS, Lee JS.
europepmc   +1 more source

A scoping review of interventions to prevent and treat adverse events during treatment of rifampin-susceptible tuberculosis. [PDF]

PLoS One
Burman WJ, Martins MF, Flynn D, Johnston J, Sinha P, Horsburgh CR.   +5 more
europepmc   +1 more source

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series. [PDF]

Br J Clin Pharmacol
Houwen JPA, de Vries Schultink AHM, Peters BJM, Ruigrok D, Schönwetter RHJ, Uijtendaal EV, Sikma MA.   +6 more
europepmc   +1 more source

Treatment of Human Brucellosis with Rifampin plus Minocycline

, 2003
Antonio Cascio, Francesco Scarlata, Sharon H. Giordano, Spinello Antinori, Claudia Colomba, Lucina Titone   +5 more
openalex   +2 more sources

Antimicrobial therapy combined with C-C chemokine receptor type 2 modulation dampens mycobacteria-aggravated monocyte activation and atherosclerosis. [PDF]

Front Cardiovasc Med
Egoavil-Espejo R, Haller A, Feria MG, Jain SK, Singh M, Zhang B, Qualls JE, Hui DY, Huaman MA.   +8 more
europepmc   +1 more source